Nitric oxide inhibits APO-1/fas-mediated cell death

Cell Growth and Differentiation

Volumn 9, Issue 5, 1998, Pages 415-422

  Dimmeler, Stefanie ^a   Haendeler, Judith ^a   Sause, Armin ^a   Zeiher, Andreas M ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

8 BROMO CYCLIC GMP; CYCLIC GMP; FAS ANTIGEN; GLUTATHIONE; NITRIC OXIDE; NITROPRUSSIDE SODIUM; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; ARTICLE; AUTOIMMUNE DISEASE; CAENORHABDITIS ELEGANS; CELL DEATH; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LEUKEMIA CELL LINE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIBODIES; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CASPASE 1; CASPASE 3; CASPASE 8; CASPASE 9; CASPASES; CYCLOHEXIMIDE; CYSTEINE ENDOPEPTIDASES; DACTINOMYCIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FAS-ASSOCIATED DEATH DOMAIN PROTEIN; GLUTATHIONE; HUMANS; JURKAT CELLS; MICE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITROPRUSSIDE; NITROSO COMPOUNDS; PENICILLAMINE; PROTEIN SYNTHESIS INHIBITORS; S-NITROSOGLUTATHIONE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES;

EID: 0031816431     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Abbas, A. K. Die and let live: eliminating dangerous lymphocytes. Cell, 84: 655-657, 1996.
2. Wyllie, A. H. Apoptosis: cell death in tissue regulation. J. Pathol., 153: 313-316, 1987.
3. Ellis, R. E., Yuan, J. Y., and Horvitz, H. R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol., 7: 663-698, 1991.
4. King, L. B., and Ashwell, J. D. Signaling for death of lymphoid cells. Curr. Opin. Immunol., 5: 368-373, 1993.
5. Krammer, P. H., Behrmann, I., Daniel, P., Dhein, J., and Debatin, K. M. Regulation of apoptosis in the immune system. Curr. Opin. Immunol., 6: 279-289, 1994.
6. Oehm, A., Behrmann, I., Falk, W., Pawlita, M., Maier, G., Klas, C., Li-Weber, M., Richards, S., Dhein, J., Trauth, B. C., et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. Biol. Chem., 267: 10709-10715, 1992.
7. Klas, C., Debatin, K. M., Jonker, R. R., and Krammer, P. H. Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol., 5: 625-630, 1993.
8. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., and Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (Lond.), 356: 314-317, 1992.
9. Enari, M., Hug, H., and Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature (Lond.), 375: 78-81, 1995.
10. Los, M., Van de Craen, M., Penning, L. C., Schenk, H., Westendorp, M., Baeuerle, P. A., Droge, W., Krammer, P. H., Fiers, W., and Schulze-Osthoff, K. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature (Lond.), 375: 81-83, 1995.
11. Tewari, M., Quan, L. T., O'Rourke, K., Desnoyers, S., Zeng, Z., Beidler, D. R., Poirier, G. G., Salvesen, G. S., and Dixit, V. M. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell, 81: 801-809, 1995.
12. Nicholson, D. W., Ali, A., Thornberry, N. A., Vaillancourt, J. P., Ding, C. K., Gallant, M., Gareau, Y., Griffin, P. R., Labelle, M., Lazebnik, Y. A., et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature (Lond.), 376: 37-43, 1995.
13. Fernandes-Alnemri, T., Litwack, G., and Alnemri, E. S. CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1β-converting enzyme. J. Biol. Chem., 269: 30761-30764, 1994.
14. Kumar, S. ICE-like proteases in apoptosis. Trends Biochem Sci., 20: 198-202, 1995.
15. Nathan, C. Nitric oxide as a secretory product of mammalian cells. FASEB J., 6: 3051-3064, 1992.
16. Lorsbach, R. B., Murphy, W. J., Lowenstein, C. J., Snyder, S. H., and Russell, S. W. Expression of the nitric oxide synthase gene in mouse macrophages activated for tumor cell killing: molecular basis for the synergy between interferon-γ and lipopolysaccharide. J. Biol. Chem., 268: 1908-1913, 1993.
17. Albina, J., Cui, S., Mateo, R., and Reichner, J. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J. Immunol., 150: 5080-5085, 1993.
18. Murray, H. W., and Teitelbaum, R. F. L-arginine-dependent reactive nitrogen intermediates and the antimicrobial effect of activated human mononuclear phagocytes. J. Infect. Dis., 165: 513-517, 1992.
19. Lander, H. M., Sehajpal, P., Levine, D. M., and Novogrodsky, A. Activation of human peripheral blood mononuclear cells by nitric oxide-generating compounds. J. Immunol., 150: 1509-1516, 1993.
20. Mannick, J. B., Asano, K., Izumi, K., Kieff, E., and Stamler, J. S. Nitric oxide produced by human B lymphocytes inhibits apoptosis and EpsteinBarr virus reactivation. Cell, 79: 1137-1146, 1994.
21. Genaro, A. M., Hortelano, S., Alvarez, A., Martinez, C., and Bosca, L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J. Clin. Invest., 95: 1884-1890, 1995.
22. Dimmeler, S., Haendeler, J., Nehls, M., and Zeiher, A. M. Suppression of apoptosis by nitric oxide via inhibition of ICE-like and CPP32-like proteases. J. Exp. Med., 185: 601-608, 1997.
23. Schulze-Osthoff, K., Krammer, P. H., and Droge, W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J., 13: 4587-4596, 1994.
24. Verheij, M., Bose, R., Lin, X. H., Yao, B., Jarvis, W. D., Grant, S., Birrer, M. J., Szabo, E., Zon, L. I., Kyriakis, J. M., Haimovitz-Friedman, A., Fuks, Z., and Kolesnick, R. N. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature (Lond.), 380: 75-79, 1996.
25. Stamler, J. S. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell, 78: 931-936, 1994.
26. DeCaterina, R., Libby, P., Peng, H. P., Thannickal, V. J., Rajavashisth, T. B., Gimbrone, M. A. J., Shin, W. S., and Liao, J. K. Nitric oxide decreases cytokine-induced endothelial activation. J. Clin. Invest., 96: 1995.
27. Zeiher, A. M., Fisslthaler, B., Schray-Utz, B., and Busse, R. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res., 76: 980-986, 1995.
28. Buttke, T. M., and Sandstrom, P. A. Oxidative stress as a mediator of apoptosis. Immunol. Today, 15: 7-10, 1994.
29. Jacobson, M. D. Reactive oxygen species and programmed cell death. Trends Biochem. Sci., 21: 83-86, 1996.
30. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E., and Dixit, V. M. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell, 85: 817-827, 1996.
31. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., and Dixit, V. M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell, 81: 505-512, 1995.
32. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V., and Wallach, D. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1-and TNF receptor-induced cell death. Cell, 85: 803-815, 1996.
33. Boldin, M. P., Mett, I. L., Varfolomeev, E. E., Chumakov, I., Shemer-Avni, Y., Camonis, J. H., and Waltach, D. Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem., 270: 387-391, 1995.
34. Hsu, H., Shu, H-B., Pan, M-G., and Goeddel, D. V. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell, 84: 299-308, 1996.
35. Kim, Y-M., de Vera, M. E., Watkins, S. C., and Billiar, T. R. Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-α-induced apoptosis by inducing heat shock protein 70 expression. J. Biol. Chem., 272: 1402-1411, 1997.
36. Enari, M., Talanian, R. V., Wong, W. W., and Nagata, S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature (Lond.), 380: 723-726, 1996.
37. Dimmeler, S., and Zeiher, A. M. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric Oxide Biol. Chem., 1: 275-281, 1997.
38. Hebestreit, H., Dibbert, B., Balatti, I., Braun, D., Schapowal, A., Blaser, K., and Simon, H-U. Disruption of Fas receptor signaling by nitric oxide in eosinophils. J. Exp. Med., 187: 415-425, 1998.
39. Yang, X., Khosravi-Far, R., Chang, H. Y., and Baltimore, D. Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell, 89: 1067-1076, 1997.
40. Chun, S. Y., Eisenhauer, K. M., Kubo, M., and Hsueh, A. J. Interleukin-1β suppresses apoptosis in rat ovarian follicles by increasing nitric oxide production. Endocrinology, 136: 3120-3127, 1995.
41. Mannick, J. B., Miao, X. Q., and Stamler, J. S. Nitric oxide inhibits Fas-induced apoptosis. J. Biol. Chem., 272: 24125-24128, 1997.
42. Molina y Vedia, L., McDonald, B., Reep, B., Brüne, B., Di Silvio, M., Billiar, T. R., and Lapetina, E. G. Nitric oxide-induced S-nitrosylation of glyceraldehyde-3-phosphate dehydrogenase inhibits enzymatic activity and increases endogenous ADP ribosylation. J. Biol. Chem., 267: 24929-24932, 1992.
43. Stamler, J. S., Simon, D. I., Osborne, J. A., Mullins, M. E., Jaraki, O., Michel, T., Singel, D. J., and Loscalzo, J. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc. Natl. Acad. Sci. USA, 89: 444-448, 1992.
44. Sarih, M., Souvannavong, V., and Adam, A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem. Biophys. Res. Commun., 191: 503-508, 1993.
45. Messmer, U. K., Ankarcrona, M., Nicotera, P., and Brüne, B. p53 expression in nitric oxide-induced apoptosis. FEBS Lett., 355: 23-26, 1994.
46. Lipton, S. A., Singel, D. J., and Stamler, J. S. Neuroprotective and neurodestructive effects of nitric oxide and redox congeners. Ann. NY Acad. Sci., 738: 382-387, 1994.
47. Nguyen, T., Brunson, D., Crespi, C. L., Penman, B. W., Wishnok, J. S., and Tannenbaum, S. R. DNA damage and mutation in human cells exposed to nitric oxide in vitro. Proc. Natl. Acad. Sci. USA, 89: 3030-3034, 1992.
48. Cameron, M. L., Granger, D. L., Weinberg, J. B., Kozumbo, W. J., and Koren, H. S. Human alveolar and peritoneal macrophages mediate fungistasis independently of L-arginine oxidation to nitrite or nitrate. Am. Rev. Respir. Dis., 142: 1313-1319, 1990.
49. Liew, F. Y. Regulation of lymphocyte functions by nitric oxide. Curr. Opin. Immunol., 7: 396-399, 1995.
50. Kleemann, R., Rothe, H., Kolb-Bachofen, V., Xie, Q. W., Nathan, C., Martin, S., and Kolb, H. Transcription and translation of inducible nitric oxide synthase in the pancreas of prediabetic BB rats. FEBS Lett., 328: 9-12, 1993.
51. Haendeler, J., Messmer, U. K., Brüne, B., Neugebauer, E., and Dimmeler, S. Endotoxic shock leads to apoptosis in vivo and reduces Bcl-2. Shock, 6: 405-409, 1996.
52. Rösi, F. A simple and rapid method for detection of apoptosis in human cells. Nucleic Acids Res., 20: 5243, 1992.
53. Bump, N. J., Hackett, M., Hugunin, M., Seshagiri, S., Brady, K., Chen, P., Ferenz, C., Franklin, S., Ghayur, T., Li, P., Licari, P., Mankovich, J., Shi, L., Greenberg, A. H., Miller, L. K., and Wong, W. W. Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35. Science (Washington DC), 269: 1885-1888, 1995.
54. Nehls, M. C., Rippe, R. A., Veloz, L., and Brenner, D. A. Transcription factors nuclear factor I and Sp1 interact with the murine collagen α 1 (I) promoter. Mol. Cell. Biol., 11: 4065-4073, 1991.
55. Ramage, P., Cheneval, D., Chvei, M., Graft, P., Hemmig, R., Heng, R., Kocher, H. P., Mackenzie, A., Memmert, K., Revesz, L., et al. Expression, refolding, and autocatalytic proteolytic processing of the interleukin-1 β-converting enzyme precursor. J. Biol. Chem., 270: 9378-9383, 1995.
56. Stamler, J. S., Simon, D. I., Jaraki, O., Osborne, J. A., Francis, S., Mullins, M., Singel, D., and Loscalzo, J. S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc. Natl. Acad. Sci. USA, 89: 8087-8091, 1992.
57. Thornberry, N. A. Interleukin-1 β converting enzyme. Methods Enzymol., 244: 615-631, 1994.